Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
Connection between Keratoconus and DED
Dry eye disease is more common in people over the age of 50. Hormonal changes, especially common in women, can cause dry eye. Other medical conditions including diabetes, glaucoma, Sjogren’s syndrome, lupus, and rheumatoid arthritis can exacerbate dry eye symptoms.…
Australian Government Allocates $35M for Blindness Research
In a significant stride towards combating global corneal blindness, the Australian Government’s Medical Research Futures Fund (MRFF) has allocated a substantial sum of $35 million to BIENCO, a consortium comprising clinical, scientific, and governance experts. The University of Wollongong (UOW)…
Mantis Photonics Launches Eye Screening Crowdfunding
Mantis Photonics, at the forefront of space-inspired technology, announced the launch of a crowdfunding campaign for its seed round. This initiative, hosted on the Capital Cel platform, aims to fuel the development of Mantis Photonics’ noninvasive health screening technology using…
Nidek, Orbis Collaborate to Boost AI Eye Screenings in Vietnam
Nidek has pledged support to Orbis International through a donation aimed at enhancing artificial intelligence (AI) screening services in Vietnam. The donation comprises six specialized fundus cameras, designed to capture retina images, thereby aiding the expansion of Orbis’s AI-driven diabetic…
Researchers Develop Game-Changing Eye Drops for DME
After 30 years of dedicated work, two researchers have achieved a remarkable breakthrough by developing eye drops that can effectively reach the back of the eye. This groundbreaking development paves the way for needle-free treatments of blinding retinal diseases, such…
Eyenovia’s Redwood City Facility Clears FDA Inspection
Eyenovia announced the successful completion of the FDA inspection for its facility in Redwood City, California, marking a significant milestone in the company’s manufacturing capabilities. This achievement signals the green light for the facility to engage in final assembly, packaging,…
2023 Recap: Top 10 Acquisitions in the Ophthalmic Industry
In 2023, the ophthalmic industry witnessed a transformative landscape shaped by strategic company acquisitions, setting the stage for significant advancements and collaborations. The top 10 acquisitions of the year highlighted a dynamic shift in the competitive dynamics of the sector.…
Glaukos Secures FDA Approval for iDose TR
Glaukos has received FDA approval for iDose TR (travoprost intracameral implant 75 mcg), a groundbreaking prostaglandin analog intracameral implant designed to reduce intraocular pressure (IOP) in individuals with ocular hypertension or open-angle glaucoma. The iDose TR procedure, sanctioned for a…
Eyenovia’s Mydcombi Approved by the FDA
Eyenovia Inc. announced that the FDA has approved Mydcombi, a groundbreaking ophthalmic spray that induces mydriasis for diagnostic procedures and short-term pupil dilation. This marks the first approved, fixed-dose combination of tropicamide and phenylephrine in the United States and also…
Top 10 Trends to Watch in Ophthalmology
The field of ophthalmology is constantly evolving with new technologies and treatments emerging every year. In the next decade, we can expect even more advancements that will revolutionize the way we approach eye care. Here are the top 10 eye…